SavedAdd your journal

Journals / Ortadoğu Tıp Dergisi / 2016 / Cilt: 8 - Sayı: 1

Pelvic Lymph Node Dissection In Patients With Prostate Cancer

Prostat Kanseri Hastalarında Pelvik Lenf Nodu Diseksiyonu

Fazlı POLAT
Süleyman YEŞİL
Ali ATAN
Pages
47–51
Publication Date
2016-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Borders, benefits and complications of PLND in this review is explained

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Important part of the patients with prostate cancer prefer undergoing radical prostatectomy RP .
📊
Key Findings & Data:However, pelvic lymph node dissection PLND along with RP is one of the most controversial issue.
💡
Conclusion & Impact:Borders, benefits and complications of PLND in this review is explained
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Prostat kanseri · pelvik lenfadenektomi · Prostate cancer

Abstract

Important part of the patients with prostate cancer prefer undergoing radical prostatectomy RP . However, pelvic lymph node dissection PLND along with RP is one of the most controversial issue. Because lymph nod involvement is not available in all cases with PKa, PLND is a time-consuming procedure and PLND must be perfomed by an experienced urologist. RP along with PLND in relevant cases is very important to obtain both correct staging and cure. Therefore, RP along with PLND is required in correct patients. According to clinical findings, radiologic imaging methods and nomograms, decision of PLND is made. Borders, benefits and complications of PLND in this review is explained

Özet

Prostat kanseri PKa tanısı konulan kişilerin önemli bir kısmı radikal prostatektomi RP olmayı tercih ederler. Ancak RP ile beraber pelvik lenf nod diseksiyonu PLND yapılması en tartışmalı konulardan birisidir. Çünkü prostat kanseri olan olguların tamamında lenf nodu tutulumu yoktur, dikkatli bir PLND zaman alıcı bir işlemdir ve deneyimli bir ürolog tarafından yapılmalıdır. Uygun kişilerde RP ile beraber PLND yapılması hem doğru evreleme hem de kür sağlanması açısından çok önemlidir. Bu nedenle doğru hastalarda RP ile beraber PLND yapılması gereklidir. Klinik bulgulara, radyolojik görüntüleme yöntemlerine ve nomogramlara dayalı olarak PLND yapma kararı verilir. Bu derlemede PLND’nun sınırları, faydası ve komplikasyonları anlatılmaktadır

🔖

Cite This Article

POLAT, F., YEŞİL, S., ATAN, A. (2016). Pelvic Lymph Node Dissection In Patients With Prostate Cancer. Ortadoğu Tıp Dergisi, Cilt: 8 - Sayı: 1, 47–51. https://ajindex.com/articles/99244

References (11)

  1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Can- cer J. 2014; 64: 9–29
  2. Y. Fradet, L. Klotz, J. Trachtenberg, and A. Zlotta. The burden of prostate cancer in Canada. J Can Urol Assoc. 2009; 3 (supplement 2): 102–108
  3. Kotb AF, Elabbady AA. Prognostic factors for the development of biochemical recurrence after radical prostatectomy. Prostate Cancer. 2011;2011:485189. doi: 10.1155/2011/485189. Epub 2011 Jun 15. Simmons MN, Stephenson AJ, Klein EA. Natural history of bioc- hemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Eur Urol. 2007; 51: 1175-1184
  4. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, et al. The contemporary management of prostate can- cer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disea- se registry. J Urol. 2004;171: 1393-401
  5. Fowler JE Jr, Whitmore WF Jr. The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer. Cancer. 1981; 47: 2941-5 Zincke H. Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immedi- ate adjuvant hormonal treatment (orchiectomy) on outcome. Uro- logy. 1989; 33 (5 Suppl): 27-36
  6. Petros JA, Catalona WJ. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically locali- zed prostate cancer. J Urol. 1992; 147: 1574-5
  7. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am. 2001; 28: 555-65
  8. Kawakami J, Meng MV, Sadetsky N, Latini DM, Duchane J, Carroll PR; CaPSURE Investigators. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE. J Urol. 2006;176 (4 pt 1): 1382-1386
  9. Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE. Pelvic lymph node dissection in prostate cancer. Eur Urol. 2009; 55:1251-65
  10. D'Amico AV, Schnall M, Whittington R, Malkowicz SB, Schultz D, Tomaszewski JE, Wein A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radi- ation therapy for clinically localized prostate cancer. JAMA. 1998; 280: 969-974
  11. Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML. Mayo Clinic validation of the D’Amico risk group classification for predicting survival